All Publications

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

Vaccine-induced CD8+ T cells are key to protection from SARS-CoV-2.

Antoun E. et al, (2023), Nature immunology

HLA-E–restricted SARS-CoV-2–specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation

Yang H. et al, (2023), Science Immunology, 8

A comprehensive analysis of the Bencao (herbal) small RNA Atlas reveals novel RNA therapeutics for treating human diseases.

Cao Y. et al, (2023), Science China. Life sciences

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

Zheng B. et al, (2023), The Lancet Regional Health - Europe, 29, 100635 - 100635

Group A Streptococcus induces CD1a-autoreactive T cells and promotes psoriatic inflammation.

Chen Y-L. et al, (2023), Science immunology, 8

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.

Milighetti M. et al, (2023), iScience, 26

Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination.

Yin Z. et al, (2023), Cell reports, 42

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

Jackson C. et al, (2023), The Lancet Respiratory Medicine

The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study

Bedawi EO. et al, (2023), American Journal of Respiratory and Critical Care Medicine, 207, 731 - 739

Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

McAuley HJC. et al, (2023), eClinicalMedicine, 57, 101896 - 101896

Kinetics of Neutralizing Antibodies against Omicron Variant in Vietnamese Healthcare Workers after Primary Immunization with ChAdOx1-S and Booster Immunization with BNT162b2

Chau NVV. et al, (2023), The American Journal of Tropical Medicine and Hygiene, 108, 137 - 144

Omicron BA.1/BA.2 infections in triple-vaccinated individuals enhance a diverse repertoire of mucosal and blood immune responses

Hornsby H. et al, (2023)

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Liew F. et al, (2023), eBioMedicine, 87, 104402 - 104402

T cells are ready for the fight against monkeypox.

Wellington D. and Dong T., (2022), Cell host & microbe, 30, 1653 - 1654

Malignant pleural effusion: Updates in diagnosis, management and current challenges

Addala DN. et al, (2022), Frontiers in Oncology, 12

Molecular Basis for the Recognition of HIV Nef138-8 Epitope by a Pair of Human Public T Cell Receptors

Ma K. et al, (2022), The Journal of Immunology, 209, 1652 - 1661

IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses

Clement M. et al, (2022), Nature Communications, 13

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Evans RA. et al, (2022), The Lancet Respiratory Medicine, 10, 761 - 775

COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records

Thygesen JH. et al, (2022), The Lancet Digital Health, 4, e542 - e557

T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles

Céspedes PF. et al, (2022), Nature Communications, 13

Cookies on this website

All Publications